Abingdon, United Kingdom

Kostas Papadopoulos

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Padlock Therapeutics, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kostas Papadopoulos. Retrieved from https://idiyas.com/inventor/kostas-papadopoulos

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 14.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Kostas Papadopoulos

Introduction

Kostas Papadopoulos is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific disorders.

Latest Patents

Kostas holds 2 patents related to his work. His latest patents include "Heteroaryl inhibitors of PAD4," which provide compounds useful as inhibitors of PAD4, compositions thereof, and methods of treating PAD4-related disorders. This invention showcases his commitment to advancing medical science and improving treatment options for patients.

Career Highlights

Kostas is currently associated with Padlock Therapeutics, Inc., where he continues to innovate and contribute to the field. His work is characterized by a focus on developing effective therapeutic solutions.

Collaborations

He collaborates with talented individuals such as Rajesh Devraj and Gnanasambandam Kumaravel, enhancing the innovative capacity of his team.

Conclusion

Kostas Papadopoulos is a dedicated inventor whose work in developing PAD4 inhibitors reflects his commitment to improving healthcare. His contributions are paving the way for new treatment methodologies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…